Modulation of the Th1/Th2 bias by an immunoglobulin histamine complex in the ovalbumin allergy mouse model

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 523-539

  Ayoub, M ^a   Lallouette, P ^b   Sutterlin B W ^b   Bessler, W G ^a   Huber, M ^a   Mittenbuhler K ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Biobasal AG   (Switzerland)

Author keywords

Histaglobin; IFN ; IL 4; Lipopeptide; Ovalbumin; Th1 Th2 bias; TNF

Indexed keywords

GAMMA INTERFERON; HISTAGLOBINE; HISTAMINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; OVALBUMIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; REGULATORY MECHANISM; SENSITIZATION; TH1 CELL; TH2 CELL;

EID: 0037387338     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00031-6     Document Type: Article

References (52)

1. Platts-Mills T.A. The role of immunoglobulin E in allergy and asthma. Am. J. Respir. Crit. Care Med. 164:2001;1-5.
2. Guenounou M. Cytokines and allergic response. Ann. Biol. Clin. 56:1998;297-304.
3. Vercelli D., Jabara H.H., Arai K., Geha R.S. Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J. Exp. Med. 169:1989;1295-1307.
4. + cells in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med. 215:1997;11-20.
5. Snapper C.M., Paul W.E. Interferon-gamma and B cell stimulatory factor-I reciprocally regulate Ig isotype production. Science. 236:1987;944-947.
6. Chretien I., Pene J., Briere F., De Waal Malefijt R., Rousset F., De Vries J.E. Regulation of human IgE synthesis: I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma. Eur. J. Immunol. 20:1990;243-251.
7. Romagnani S. Regulation and deregulation of human IgE synthesis. Immunol. Today. 11:1990;316-321.
8. Purkerson J., Isakson P. A two-signal model for regulation of immunoglobulin isotype switching. FASEB J. 6:1992;3245-3252.
9. Stevens T.L., Bossie A., Sanders V.M., Fernandez-Bottran R., Coffman R.L., Mosmann T.R.et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334:1988;255-258.
10. Paul W.E. Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell. 57:1989;521-524.
11. Finkelman F.D., Holmes J., Katona I.M., Urban J.F. Jr., Beckmann M.P., Park L.S.et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:1990;303-333.
12. Finkelman F.D., Urban J.F. Jr., Beckmann M.P., Schooley K.A., Holmes J.M., Katona I.M. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. Int. Immunol. 3:1991;599-607.
13. Finkelman F.D., Katona I.M., Urban J.F. Jr., Snapper C.M., Ohara J., Paul W.E. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to lymphokine B-cell stimulatory factor 1. Proc. Natl. Acad. Sci. 83:1986;9675-9678.
14. Finkelman F.D., Katona I.M., Urban J.F. Jr., Holmes J., Ohara J., Tung A.S.et al. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141:1988;2335-2341.
15. Liebhart J., Zak-Najmark T., Malolepszy J., Nadobna G., Liebhart E. Changes of histaminopexy in patients with bronchial asthma and chronic urticaria after histaglobin administration. Arch. Immunol. Ther. Exp. 34:1986;385-389.
16. Gushchin I.S., Luss L.V., Il'ina N.I., Larina O.N., Pakhomova L.A. Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria. Ter. Arkh. 71:1999;57-62.
17. Paci A., Taddeucci-Brunelli G., Barachini P., Magliaccio P., Pierini G., Crimaldi G. Therapy of atopic dermatitis in children. Study on the use of a desensitizing preparation. Pediatr. Med. Chir. 8:1986;839-844.
18. Ayoub M., Mittenbühler K., Sütterlin B.W., Bessler W.G. The anti-allergic drug histaglobin inhibits NF-kappaB nuclear translocation and down-regulates proinflammatory cytokines. Int. J. Immunopharmacol. 22:2000;755-763.
19. Ishikawa T., Shimada T., Kessoku N., Kiyoi M. Inhibition of rat mast cell degranulation and histamine release by histamine-rat gammaglobulin conjugate. Int. Arch. Allergy Immunol. 59:1979;403-407.
20. Yoshii H., Fukata-Yamazaki Y., Yamamoto K., Yago H., Yanagihara Y., Okudaira H. A complex of histamin/mouse γ-globulin preferentially inhibits allergen-induced peritoneal accumulation of eosinophils, but not neutrophils, in mice. J. Allergy Clin. Immunol. 100:1997;809-816.
21. Renz H., Smith H.R., Henson J.E., Ray B.S., Irvin C.G., Gelfand E.W. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J. Allergy Clin. Immunol. 89:1992;1127-1138.
22. Herz U., Braun A., Rückert T., Renz H. Various immunological phenotypes are associated with increased airway responsiveness. Clin. Exp. Allergy. 28:1998;628-634.
23. Jarmann E.R., Kuba A., Montermann E., Bartlett R.R., Reske-Kunz A.B. Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide. Clin. Exp. Immunol. 115:1999;221-228.
24. Valenta R. The future of antigen-specific immunotherapy of allergy. Nature Rev. Immunol. 6:2002;446-453.
25. Kilmon M.A., Ghirlando R., Strub M.P., Beavil R.L., Gould H.J., Conrad D.H. Regulation of IgE production requires oligomerization of CD23. J. Immunol. 167:2001;3139-3145.
26. Malaviya R., Uckun F.M. Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in mice. Am. J. Ther. 8:2001;309-316.
27. Worm M., Herz U., Krah J.M., Renz H., Henz B.M. Effects of retinoids on in vitro and in vivo IgE production. Int. Arch. Allergy Immunol. 124:2001;233-236.
28. von Garnier C., Astori M., Kettner A., Dufour N., Heusser C., Corradin G.et al. Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis. Eur. J. Immunol. 30:2000;1638-1645.
29. Hamelmann E., Tadeda K., Oshiba A., Gelfand E.W. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness. A murine model. Allergy. 54:1999;297-305.
30. Sudowe S., Montermann E., Steitz J., Tuting T., Knop J., Reske-Kunz A.B. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy. Gene Ther. 9:2002;147-156.
31. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. 38:2002;881-885.
32. Knopf P.M. Immunomodulation and allergy. Allergy Asthma Proc. 21:2000;215-220.
33. Broide D., Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol. Rev. 179:2001;163-172.
34. Lukacs N.W. Migration of helper T-lymphocytes subsets into inflamed tissues. J. Allergy Clin. Immunol. 106:2000;264-269.
35. Greenfeder S., Umland S.P., Cuss F.M., Chapman R.W., Egan R.W. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir. Res. 2:2001;71-79.
36. Mordvinov V.A., Sanderson C.J. Regulation of IL-5 expression. Arch. Immunol. Ther. Exp. 49:2001;345-351.
37. Walsh G.M. Eosinophil granule proteins and their role in disease. Curr. Opin. Hematol. 8:2001;28-33.
38. Wynn T.A., Eltoum I., Oswald I.P., Cheever A.W., Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179:1994;1551-1561.
39. Gavett S.H., O'Hearn D.J., Li X., Huang S.K., Finkelman F.D., Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182:1995;1527-1536.
40. Kung T.T., Stelts D.M., Zurcher J.A., Jones H., Umland S.P., Egan R.W.et al. Interferon-gamma and antibodies to interleukin-5 and interleukin-4 inhibit pulmonary eosinophilia in allergic mice. Inflamm. Res. 44(Suppl. 2):1995;185-186.
41. Paludan S.R. Interleukin-4 and interferon-gamma; the quintessence of a mutual antagonistic relationship. Scand. J. Immunol. 48:1998;459-468.
42. Boothby M., Mora A.L., Aronica M.A., Youn J., Sheller J.R., Goenka S.et al. IL-4 signaling, gene transcription regulation, and the control of effector T cells. Immunol. Res. 23:2001;179-191.
43. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85:2000;9-18.
44. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS. 103:1995;161-179.
45. Viola J.P., Rao A. Molecular regulation of cytokine expression during the immune response. J. Clin. Immunol. 19:1999;98-108.
46. So E.Y., Park H.H., Lee C.E. IFN-gamma and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression. J. Immunol. 165:2000;5472-5479.
47. Durham S.R. New insights into the mechanisms of immunotherapy. Eur. Arch. Otorhinolaryngol. 225:1995;64-67.
48. Kang K.W., Kim T.S., Kim K.M. Interferon-gamma- and interleukin-4-targeted gene therapy for atopic allergic disease. Immunology. 97:1999;462-465.
49. Fahy J.V. Reducing IgE levels as a strategy for the treatment of asthma. Clin. Exp. Allergy. 30:2000;16-21.
50. Kurup V.P., Murali P.S., Guo J., Choi H., Banerjee B., Fink J.N.et al. Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy. 52:1997;1215-1221.
51. Renz H., Enssle K., Lauffer L., Kurrle R., Gelfand E.W. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int. Arch. Allergy Immunol. 106:1995;46-54.
52. Rubira G.N. Tumor necrosis factor. Allergol. Immunopathol. 28:2000;115-119.